Allergol Immunopathol (Madr)
August 2019
Objective: To describe potential regional variations in therapies for severe asthma exacerbations in Chilean children and estimate the associated health expenditures.
Methods: Observational prospective cohort study in 14 hospitals over a one-year period. Children five years of age or older were eligible for inclusion.
Allergol Immunopathol (Madr)
January 2019
Background: Asthma hospitalization rates in Chilean children have increased in the last 14 years, but little is known about the factors associated with this.
Objective: Describe clinical characteristics of children hospitalized for asthma exacerbation.
Methods: Observational prospective cohort study in 14 hospitals.
Interstitial lung disease (ILD) is rare and encompasses a heterogeneous group of diseases, and is even rarer in children than in adults. ILDs compromise more than 100 different entities, including pulmonary alveolar proteinosis (PAP). There are many causes of PAP in children, including surfactant protein gene mutations (SFTPB, SFTPC, ABCA3, TTF-1), GMCSF receptor mutations and antigranulocyte-macrophage colony-stimulating factor autoantibodies.
View Article and Find Full Text PDFBackground: Very few patients are presented to ethics committees, and individual ethics consultations are a response to this situation. At the intensive care unit (ICU) in Clínica Alemana, Santiago Chile, an ethics consultation system was organized coordinated with the ethics committee.
Aim: To report an evaluation of this ethics consultation system.